Marco Vitale
Marco Vitale
Dipartimento di Medicina e Chirurgia, Università di Parma
Email verificata su
Citata da
Citata da
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
A Moretta, C Bottino, M Vitale, D Pende, C Cantoni, MC Mingari, ...
Annual review of immunology 19 (1), 197-223, 2001
Receptors for HLA class-I molecules in human natural killer cells
A Moretta, C Bottino, M Vitale, D Pende, R Biassoni, MC Mingari, ...
Annual review of immunology 14 (1), 619-648, 1996
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non–major histocompatibility complex–restricted tumor cell lysis
M Vitale, C Bottino, S Sivori, L Sanseverino, R Castriconi, E Marcenaro, ...
The Journal of experimental medicine 187 (12), 2065-2072, 1998
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino, R Castriconi, D Pende, P Rivera, M Nanni, B Carnemolla, ...
The Journal of experimental medicine 198 (4), 557-567, 2003
Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
H Ikeda, B Lethé, F Lehmann, N Van Baren, JF Baurain, C De Smet, ...
Immunity 6 (2), 199-208, 1997
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains
N Wagtmann, R Biassoni, C Cantoni, S Verdiani, MS Malnati, M Vitale, ...
Immunity 2 (5), 439-449, 1995
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells
R Castriconi, C Cantoni, M Della Chiesa, M Vitale, E Marcenaro, R Conte, ...
Proceedings of the National Academy of Sciences 100 (7), 4120-4125, 2003
p46, a novel natural killer cell–specific surface molecule that mediates cell activation
S Sivori, M Vitale, L Morelli, L Sanseverino, R Augugliaro, C Bottino, ...
The Journal of experimental medicine 186 (7), 1129-1136, 1997
P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of …
A Moretta, M Vitale, C Bottino, AM Orengo, L Morelli, R Augugliaro, ...
The Journal of experimental medicine 178 (2), 597-604, 1993
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells
S Sivori, M Falco, M Della Chiesa, S Carlomagno, M Vitale, L Moretta, ...
Proceedings of the National Academy of Sciences 101 (27), 10116-10121, 2004
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
A Moretta, S Sivori, M Vitale, D Pende, L Morelli, R Augugliaro, C Bottino, ...
The Journal of experimental medicine 182 (3), 875-884, 1995
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
C Cantoni, C Bottino, M Vitale, A Pessino, R Augugliaro, A Malaspina, ...
The Journal of experimental medicine 189 (5), 787-796, 1999
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
D Pende, C Cantoni, P Rivera, M Vitale, R Castriconi, S Marcenaro, ...
European journal of immunology 31 (4), 1076-1086, 2001
NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor
M Vitale, MD Chiesa, S Carlomagno, D Pende, M Arico, L Moretta, ...
Blood 106 (2), 566-571, 2005
Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes
A Moretta, R Biassoni, C Bottino, D Pende, M Vitale, A Poggi, MC Mingari, ...
Immunological reviews 155 (1), 105-117, 1997
Human natural killer cell receptors and co‐receptors
R Biassoni, C Cantoni, D Pende, S Sivori, S Parolini, M Vitale, C Bottino, ...
Immunological reviews 181 (1), 203-214, 2001
NK cells and cancer
L Zamai, C Ponti, P Mirandola, G Gobbi, S Papa, L Galeotti, L Cocco, ...
The Journal of Immunology 178 (7), 4011-4016, 2007
Effector and regulatory events during natural killer–dendritic cell interactions
L Moretta, G Ferlazzo, C Bottino, M Vitale, D Pende, MC Mingari, ...
Immunological reviews 214 (1), 219-228, 2006
The human leukocyte antigen (HLA)-C-specific activatory or inhibitory natural killer cell receptors display highly homologous extracellular domains but differ in their …
R Biassoni, C Cantoni, M Falco, S Verdiani, C Bottino, M Vitale, R Conte, ...
The Journal of experimental medicine 183 (2), 645-650, 1996
The natural killer cell‐mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig‐like receptors
MD Chiesa, M Vitale, S Carlomagno, G Ferlazzo, L Moretta, A Moretta
European journal of immunology 33 (6), 1657-1666, 2003
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20